Edges in Network
| Network | GSE18864_egf1520 - GSE18864 - SiGN-BN HC+Bootstrap |
| Network Description | Tumor expression data from neoadjuvant trial of cisplatin monotherapy in triple negative breast cancer patients |
| Node | CSGALNACT2 |
| Upstream (Parents) |
|---|
| (<<) CDH22 → CSGALNACT2 |
| (<<) HAS3 → CSGALNACT2 |
| (<<) MMP14 → CSGALNACT2 |
| (<<) MVK → CSGALNACT2 |
| (<<) PRKCG → CSGALNACT2 |
| (<<) RHOD → CSGALNACT2 |
| (<<) RHOT2 → CSGALNACT2 |
| (<<) ROCK1 → CSGALNACT2 |
| (<<) SMTN → CSGALNACT2 |
| (<<) SYN1 → CSGALNACT2 |
| Downstream (Children) |
|---|
| CSGALNACT2 → ABLIM1 (>>) |
| CSGALNACT2 → ADAM9 (>>) |
| CSGALNACT2 → ADCY7 (>>) |
| CSGALNACT2 → ANKDD1A (>>) |
| CSGALNACT2 → B3GNT2 (>>) |
| CSGALNACT2 → BCAR3 (>>) |
| CSGALNACT2 → BMPR2 (>>) |
| CSGALNACT2 → CASP3 (>>) |
| CSGALNACT2 → CISH (>>) |
| CSGALNACT2 → DYNC1LI2 (>>) |
| CSGALNACT2 → ETS1 (>>) |
| CSGALNACT2 → GLS (>>) |
| CSGALNACT2 → HDAC5 (>>) |
| CSGALNACT2 → HIPK1 (>>) |
| CSGALNACT2 → LCE3D (>>) |
| CSGALNACT2 → MAP2K1 (>>) |
| CSGALNACT2 → MAP3K8 (>>) |
| CSGALNACT2 → MAPK1 (>>) |
| CSGALNACT2 → MERTK (>>) |
| CSGALNACT2 → MYL6B (>>) |
| CSGALNACT2 → PPP1R3B (>>) |
| CSGALNACT2 → PRDX6 (>>) |
| CSGALNACT2 → PTPN12 (>>) |
| CSGALNACT2 → RCBTB1 (>>) |
| CSGALNACT2 → RCOR1 (>>) |
| CSGALNACT2 → RPL35 (>>) |
| CSGALNACT2 → RPS14 (>>) |
| CSGALNACT2 → RYK (>>) |
| CSGALNACT2 → SGMS2 (>>) |
| CSGALNACT2 → SOCS5 (>>) |
| CSGALNACT2 → SPR (>>) |
| CSGALNACT2 → SYNGR4 (>>) |
| CSGALNACT2 → SYNJ2 (>>) |
| CSGALNACT2 → THBS1 (>>) |
| CSGALNACT2 → TPM4 (>>) |
| CSGALNACT2 → TRIM32 (>>) |
| CSGALNACT2 → UBE2D4 (>>) |
| CSGALNACT2 → VEGFC (>>) |
| CSGALNACT2 → YWHAE (>>) |
| CSGALNACT2 → ZNF224 (>>) |
